NCT00031980View on ClinicalTrials.gov

Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
AnemiaLeukemiaNeutropeniaThrombocytopenia
Interventions
DRUG

cyclosporine

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00031980 - Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer | Biotech Hunter | Biotech Hunter